Upper gastrointestinal (GI) neoplasia account for 35% of GI cancers and 1.5 million cancer-
related deaths every year. Despite its efficacy in preventing cancer mortality, diagnostic …

Gastric cancer is the second leading cause of cancer incidence in Japan, although gastric
cancer mortality has decreased over the past few decades. This decrease is attributed to a …

Patients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric
adenocarcinoma. This underscores the importance of diagnosis and risk stratification for …

Gastric cancer (GC) is a multifactorial process, accompanied by alterations in metabolic
pathways. Non‐invasive metabolic profiling facilitates GC diagnosis at early stage leading to …

This ESGE Position Statement defines the expected value of artificial intelligence (AI) for the
diagnosis and management of gastrointestinal neoplasia within the framework of the …

Helicobacter pylori Infection is formally recognised as an infectious disease, an entity that is
now included in the International Classification of Diseases 11th Revision. This in principle …

Background: Linked color imaging (LCI) is a new image-enhanced endoscopy technique
that allows users to recognize slight differences in mucosal color. Objective: To compare the …

Background White light endoscopy is a pivotal first-line tool for the detection of gastric
neoplasms. However, gastric neoplasms can be missed during upper gastrointestinal …

Objective Early detection of gastric cancer has been the topic of major efforts in high
prevalence areas. Whether advanced imaging methods, such as second-generation narrow …

Background and Aims Narrow-band imaging with magnifying endoscopy (ME-NBI) has
shown advantages in the diagnosis of early gastric cancer (EGC). However, proficiency in …